» Articles » PMID: 38258012

Microbiologic Findings in a Cohort of Patients with Erythema Migrans

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Jan 23
PMID 38258012
Authors
Affiliations
Soon will be listed here.
Abstract

Erythema migrans (EM) is the initial and the most frequent clinical manifestation of Lyme borreliosis (LB). Herein, we report on the capacity of culture and serology for the demonstration of infection in a cohort of 292 patients diagnosed with typical EM at a single medical center. The median duration of EM at diagnosis was 12 days, and the largest diameter was 16 cm; 252 (86.3%) patients presented with solitary EM, whereas 40 (13.7%) had multiple EM. A total of 95/292 (32.5%) patients had positive IgM, and 169 (57.9%) had positive IgG serum antibodies; the isolation rate was 182/292 (62.3%). The most frequent species by far was (142/148, 95.9%) while (2.7%) and s.s. (1.4%) were rare. IgM seropositivity was associated with a younger age, multiple EM and the absence of underlying chronic illness; IgG seropositivity was associated with the duration of EM at diagnosis, the diameter of the EM, having had a previous episode of LB and the absence of symptoms at the site of the EM. Furthermore, the isolation rate was statistically significantly lower in patients with positive IgM antibodies. Although microbiologic analyses are not needed for the diagnosis of typical EM, they enable insights into the etiology and dynamics of the immune response in the course of early LB.

Citing Articles

Preclinical Evidence for the Protective Capacity of Antibodies Induced by Lyme Vaccine Candidate VLA15 in People.

Lundberg U, Hochreiter R, Timofoyeva Y, Kanevsky I, Meinke A, Anderson A Open Forum Infect Dis. 2024; 11(9):ofae467.

PMID: 39233712 PMC: 11372474. DOI: 10.1093/ofid/ofae467.

References
1.
Ruzic-Sabljic E, Strle F . Comparison of growth of Borrelia afzelii, B. garinii, and B. burgdorferi sensu stricto in MKP and BSK-II medium. Int J Med Microbiol. 2004; 294(6):407-12. DOI: 10.1016/j.ijmm.2004.08.002. View

2.
Ruzic-Sabljic E, Zore A, Strle F . Characterization of Borrelia burgdorferi sensu lato isolates by pulsed-field gel electrophoresis after MluI restriction of genomic DNA. Res Microbiol. 2008; 159(6):441-8. DOI: 10.1016/j.resmic.2008.05.005. View

3.
Maraspin V, Ogrinc K, Rojko T, Bogovic P, Ruzic-Sabljic E, Kastrin A . Characteristics of spirochetemic patients with a solitary erythema migrans skin lesion in Europe. PLoS One. 2021; 16(4):e0250198. PMC: 8062101. DOI: 10.1371/journal.pone.0250198. View

4.
Guerin M, Shawky M, Zedan A, Octave S, Avalle B, Maffucci I . Lyme borreliosis diagnosis: state of the art of improvements and innovations. BMC Microbiol. 2023; 23(1):204. PMC: 10392007. DOI: 10.1186/s12866-023-02935-5. View

5.
van den Wijngaard C, Hofhuis A, Simoes M, Rood E, van Pelt W, Zeller H . Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Euro Surveill. 2017; 22(27). PMC: 5508331. DOI: 10.2807/1560-7917.ES.2017.22.27.30569. View